Nobel Prize in Medicine recognizes the discovery of HPV and HIV – how long ago was it?
The background
On October 6, 2008 it was announced that Harald zur Hausen, Françoise Barré-Sinoussi and Luc Montagnier would receive the Nobel Prize in Physiology or Medicine. The German cancer researcher zur Hausen receives half of the prize for the discovery that certain human papilloma viruses, or HPV for short, cause cervical cancer. The two French researchers shared the other half for the discovery of the human immunodeficiency virus HIV. Zur Hausen's work changes the understanding of a common cancer: a viral infection may be behind its development, even though most HPV infections do not lead to cancer. This finding creates an essential basis for preventative vaccines against particularly dangerous HPV types. At the time of the Nobel Prize decision, such vaccinations were already available. The discovery of HIV, in turn, enables targeted blood tests and forms a basis for the development of therapies against the infection, which, if left untreated, can lead to AIDS. Together, the award-winning works demonstrate how the identification of a pathogen can fundamentally change diagnosis, prevention and treatment.